Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 3 3Phase 2 3Phase 1/2 3Phase 1 3Phase 4 1

Status

Recruiting 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 3Thoracic 2Breast 2Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 174Neoplasm Metastasis 139Neoplasms 133Leukemia, Myeloid, Acute 127Colorectal Neoplasms 126Breast Neoplasms 113Melanoma 88Ovarian Neoplasms 87Prostatic Neoplasms 86Recurrence 84Multiple Myeloma 79Pancreatic Neoplasms 74Squamous Cell Carcinoma of Head and Neck 72Glioblastoma 71Lung Neoplasms 70Lymphoma, Non-Hodgkin 62Myelodysplastic Syndromes 60Triple Negative Breast Neoplasms 56Stomach Neoplasms 52Glioma 52Precursor Cell Lymphoblastic Leukemia-Lymphoma 49Endometrial Neoplasms 47Carcinoma, Renal Cell 47Small Cell Lung Carcinoma 46Lymphoma, Large B-Cell, Diffuse 44Brain Neoplasms 43Carcinoma, Hepatocellular 41Sarcoma 39Advanced Solid Tumors 39Lymphoma, Follicular 38

Interventions

Loperamide 1Fulvestrant 1Fecal Microbiota Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Uterine Neoplasms × 90 days × Clear all
NCT07038369 2026-06-03

A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations

Atavistik Bio, Inc

Phase 1 Active not recruiting
134 enrolled
BreastGenitourinaryGynecologic

Breast Diseases, Breast Neoplasms, Uterine Cervical Neoplasms, Genital Neoplasms, Female, Neoplasms, Neoplasms by Site, Ovarian Neoplasms, Prostatic Neoplasms, Urogenital Neoplasms, Uterine Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT07542704 2026-04-21

A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies

Kumquat Biosciences Inc.

Phase 1 Not yet recruiting
48 enrolled
GastrointestinalGynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Uterine Neoplasms, Colorectal Neoplasms

NCT04038619 2026-03-20

Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients

M.D. Anderson Cancer Center

Phase 1 Recruiting
40 enrolled
BreastDermatologicGynecologicThoracic

Breast Neoplasms, Uterine Cervical Neoplasms, Colitis, Diarrhea, Lung Neoplasms, Melanoma, Ovarian Neoplasms, Urogenital Neoplasms, Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡